This page shows the latest Yiruike news and features for those working in and with pharma, biotech and healthcare.
Qilu Pharma’s Yiruike licensed as first-line NSCLC treatment. AstraZeneca's lung cancer therapy Iressa (gefitinib) is facing generic competition in China, after Qilu Pharmaceutical's Yiruike won marketing authorisation ... The new generic, Yiruike, has
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...